Catalysts

• (Diabetes) Oral Insulin: Data from new tablet prototype; Data from European multi-dose study

• (Anticoagulants) Solid Oral UF Heparin: Data from multiple arm study

• (Obesity) Oral PYY3-36: Initiate first-into-mansafety studies (FIMSS)

• (Various) Feasibility Candidates: Progress programs into partnerships

Previous slide

Next slide

Back to first slide

View graphic version